کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2774978 1152303 2016 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection
ترجمه فارسی عنوان
آنتی بادی های تثبیت کننده تکمیلی در برابر آنتی ژن های HLA و MICA دناتوره با رد آنتی بادی واسطه در ارتباط است
کلمات کلیدی
HLA، آنتی ژن لکوسیت انسانی؛ MICA، MHC کلاس I ژن A مرتبط با زنجیره؛ AMR، آنتی بادی واسطه رد؛ CMR، آنتی بادی تثبیت کننده rejectionc1q؛ آنتی بادی HLA؛ آنتی بادی MICA؛ آنتی ژن دناتوره؛ آنتی بادی epitope؛ پیوند کلیه؛ آنتی بادی واسطه
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوشیمی بالینی
چکیده انگلیسی

BackgroundWe have found antibodies against denatured HLA class I antigens in the serum of allograft recipients which were not significantly associated with graft failure. It is unknown whether transplant recipients also have denatured HLA class II and MICA antibodies. The effects of denatured HLA class I, class II, and MICA antibodies on long-term graft outcome were further investigated based on their ability to fix complement c1q.Materials and methodsIn this 4-year retrospective cohort study, post-transplant sera from 975 kidney transplant recipients were tested for antibodies against denatured HLA/MICA antigens and these antibodies were further classified based on their ability to fix c1q.ResultsThirty percent of patients had antibodies against denatured HLA class I, II, or MICA antigens. Among them, 8.5% and 21.5% of all patients had c1q-fixing and non c1q-fixing antibodies respectively. There was no significant difference on graft survival between patients with or without antibodies against denatured HLA/MICA. However, when these antibodies were further classified according to their ability to fix c1q, patients with c1q-fixing antibodies had a significantly lower graft survival rate than patients without antibodies or patients with non c1q-fixing antibodies (p = 0.008). In 169 patients who lost renal grafts, 44% of them had c1q-fixing antibodies against denatured HLA/MICA antigens, which was significantly higher than that in patients with functioning renal transplants (25%, p < 0.0001). C1q-fixing antibodies were more significantly associated with graft failure caused by AMR (72.73%) or mixed AMR/CMR (61.9%) as compared to failure due to CMR (35.3%) or other causes (39.2%) (p = 0.026).ConclusionsTransplant recipients had antibodies against denatured HLA class I, II, and MICA antigens. However, only c1q-fixing antibodies were associated with graft failure which was related to antibody mediated rejection.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental and Molecular Pathology - Volume 100, Issue 1, February 2016, Pages 45–50
نویسندگان
, , , , , , ,